The Methylation Test That Decides Brain Cancer Treatment Faces a Reckoning
A new Mayo Clinic review in the Journal of Neuro-Oncology examines how MGMT promoter methylation guides brain tumor treatment, why ...
A new Mayo Clinic review in the Journal of Neuro-Oncology examines how MGMT promoter methylation guides brain tumor treatment, why ...
A large paired-cohort study finds MGMT promoter methylation remains quantitatively stable in 84 percent of recurrent gliomas, with apparent status ...
A retrospective study at University Hospital Bonn independently confirms that blood group O is associated with significantly longer progression-free and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine